Department of Animal Sciences, Ohio Agricultural Research and Development Center, The Ohio State University, Wooster 44691.
Kemin Industries Inc., Des Moines, IA 50317.
J Dairy Sci. 2019 Dec;102(12):11026-11039. doi: 10.3168/jds.2019-17125. Epub 2019 Sep 20.
An experiment was conducted to examine effects of prepartum, postpartum, or continuous prepartum and postpartum supply of rumen-protected lysine (RPLys) and rumen-protected methionine (RPMet) on performance and blood metabolites of transition cows. The experiment consisted of a prepartum (3 wk), postpartum (3 wk), and carryover (10 wk) period. Eighty-eight prepartum cows (36 primiparous and 52 multiparous cows) were blocked by parity and expected calving date and assigned to 1 of 4 treatments arranged factorially. Treatments were a prepartum diet (12% crude protein on a dry matter basis) without (Pre-) or with supplemental RPLys (10 g of digestible Lys/cow per day) and RPMet (4 g of digestible Met/cow per day; Pre+) followed by postpartum diets (16% crude protein on a dry matter basis) without (Post-) or with supplemental RPLys (26 g of digestible Lys/cow per day) and RPMet (11 g of digestible Met/cow per day; Post+). Prepartum, only 2 treatments were applied, but postpartum cows received treatments of Pre-Post-, Pre-Post+, Pre+Post-, or Pre+Post+. During the prepartum period, treatment did not affect dry matter intake and body weight. During the postpartum period, milk protein content was greater (3.23 vs. 3.11%) for Post+ compared with Post- independent of prepartum treatment. However, dry matter intake, body weight, milk yield, and yields of milk components were not affected by Post+ versus Post-. No effects of prepartum treatment or interactions between pre- and postpartum treatments were observed on postpartum performance of cows. No effects of pre- and postpartum supplementation of RPLys and RPMet on performance during the carryover period were found except prepartum supplementation of RPLys and RPMet decreased somatic cell count (4.60 vs. 4.83; log transformed) compared with Pre- in the postpartum period and this effect continued during the carryover period [i.e., 4.42 and 4.55 (log transformed) for Pre+ and Pre-, respectively]. Prepartum supplementation of RPLys and RPMet increased or tended to increase plasma concentration of Lys, Met, and branched-chain AA compared with Pre- in prepartum cows. Cows on Post+ tended to have greater plasma Lys concentration compared with Post-, but plasma Met concentration was not affected. Health events of postpartum cows were not affected by treatments. In conclusion, we did not observe positive effects of supplementing with RPLys and RPMet on performance of prepartum and postpartum cows. However, prepartum supply of RPLys and RPMet may have potential to improve udder health and immune status of fresh cows.
进行了一项实验,以研究产前、产后或产前和产后持续供应瘤胃保护性赖氨酸(RPLys)和瘤胃保护性蛋氨酸(RPMet)对过渡期奶牛的性能和血液代谢物的影响。该实验包括产前(3 周)、产后(3 周)和延续期(10 周)。88 头产前奶牛(36 头初产牛和 52 头经产牛)按胎次和预期产犊日期分组,并按 4 种处理因素的组合分配到 1 种处理中。处理方法是产前(干物质基础上 12%粗蛋白)不添加(Pre-)或添加补充 RPLys(每天每头牛可消化 Lys10 克)和 RPMet(每天每头牛可消化 Met4 克)和产后(干物质基础上 16%粗蛋白)不添加(Post-)或添加补充 RPLys(每天每头牛可消化 Lys26 克)和 RPMet(每天每头牛可消化 Met11 克);产后(Post+)。在产前阶段,仅应用了 2 种处理方法,但产后奶牛接受了 Pre-Post-、Pre-Post+、Pre+Post-或 Pre+Post+的处理。在产前阶段,处理方法对干物质采食量和体重没有影响。在产后阶段,与 Post-相比,Post+的牛奶蛋白含量更高(3.23%对 3.11%),而与产前处理无关。然而,干物质采食量、体重、产奶量和牛奶成分产量不受 Post+与 Post-的影响。在产后奶牛的表现方面,未观察到产前处理或产前和产后处理之间的相互作用的影响。在延续期,除了产前补充 RPLys 和 RPMet 降低了产后奶牛的体细胞计数(4.60 对 4.83;对数转换),与 Pre-相比,未发现 RPLys 和 RPMet 对产前和产后补充对性能的任何影响。在产前奶牛中,与 Pre-相比,补充 RPLys 和 RPMet 增加或倾向于增加赖氨酸、蛋氨酸和支链氨基酸的血浆浓度。与 Post-相比,Post+的奶牛血浆赖氨酸浓度有增加的趋势,但血浆蛋氨酸浓度没有受到影响。产后奶牛的健康事件不受处理的影响。总之,我们没有观察到补充 RPLys 和 RPMet 对产前和产后奶牛性能的积极影响。然而,产前供应 RPLys 和 RPMet 可能有潜力改善新产奶牛的乳房健康和免疫状态。